Search research articles
Contact Us
Filters
Showing results (311-320 of 760) with videos related to
Page
of 76
Sort By:
Journal of Thrombosis and Thrombolysis
|
August 28, 2012
Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers
Antonio Tello-Montoliu, Fabiana Rollini, Bhaloo Desai, et al.
Drugs
|
July 29, 2024
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Mattia Galli, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 24, 2011
Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation
Giuseppe Musumeci, Roberta Rossini, Corrado Lettieri, et al.
Thrombosis and Haemostasis
|
February 14, 2019
Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression
Isabella Massimi, Laura Alemanno, Maria Luisa Guarino, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications
Alessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
JACC. Cardiovascular Interventions
|
March 7, 2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score
Dominick J Angiolillo, Davide Capodanno, Nicolas Danchin, et al.
Thrombosis Research
|
November 18, 2008
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients
Dominick J Angiolillo, Piera Capranzano, Bhaloo Desai, et al.
BMC Medical Genetics
|
September 7, 2007
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
Ugo Cavallari, Elisabetta Trabetti, Giovanni Malerba, et al.
Journal of the American College of Cardiology
|
April 24, 2012
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study
Dietmar Trenk, Gregg W Stone, Meinrad Gawaz, et al.
Journal of Cardiovascular Development and Disease
|
May 26, 2026
In Hospital Assessment and Management of High Bleeding Risk in Patients with ST-Elevation Myocardial Infarction (STEMI)
Sanghoon Kim, Alberto Piserra-López, Salvatore Giordano, et al.
Page
of 76
Search research articles
Search
Showing results (311-320 of 760) with videos related to
Sort By:
Page
of 76
Journal of Thrombosis and Thrombolysis
|
August 28, 2012
Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers
Antonio Tello-Montoliu, Fabiana Rollini, Bhaloo Desai, et al.
Drugs
|
July 29, 2024
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Mattia Galli, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 24, 2011
Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation
Giuseppe Musumeci, Roberta Rossini, Corrado Lettieri, et al.
Thrombosis and Haemostasis
|
February 14, 2019
Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression
Isabella Massimi, Laura Alemanno, Maria Luisa Guarino, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 20, 2016
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications
Alessandro Lupi, Alon Schaffer, Andrea Rognoni, et al.
JACC. Cardiovascular Interventions
|
March 7, 2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score
Dominick J Angiolillo, Davide Capodanno, Nicolas Danchin, et al.
Thrombosis Research
|
November 18, 2008
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients
Dominick J Angiolillo, Piera Capranzano, Bhaloo Desai, et al.
BMC Medical Genetics
|
September 7, 2007
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
Ugo Cavallari, Elisabetta Trabetti, Giovanni Malerba, et al.
Journal of the American College of Cardiology
|
April 24, 2012
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study
Dietmar Trenk, Gregg W Stone, Meinrad Gawaz, et al.
Journal of Cardiovascular Development and Disease
|
May 26, 2026
In Hospital Assessment and Management of High Bleeding Risk in Patients with ST-Elevation Myocardial Infarction (STEMI)
Sanghoon Kim, Alberto Piserra-López, Salvatore Giordano, et al.
Page
of 76